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http://dx.doi.org/10.1016/j.jfma.201
0929-6646/Copyright ª 2014, ElsevierBackground/purpose: A portion of patients with oral lichen planus (OLP) may have nutritional
deficiency. This study evaluated whether there was an intimate association of the deficiencies
of hemoglobin (Hb), iron, vitamin B12, and folic acid and high blood homocysteine level with
OLP.
Methods: The blood Hb, iron, vitamin B12, folic acid, and homocysteine concentrations in 352
OLP patients were measured and compared with the corresponding levels in 352 age- and sex-
matched healthy control participants.
Results: We found that 77 (21.9%) OLP patients, 48 (13.6%) OLP patients, 25 (7.1%) OLP pa-
tients, and one (0.3%) OLP patient had deficiencies of Hb (men < 13 g/dL, women < 12 g/
dL), iron (< 60 mg/dL), vitamin B12 (< 200 pg/mL), and folic acid (< 4 ng/mL), respectively.
Moreover, 52 (14.8%) OLP patients had abnormally high blood homocysteine level. OLP patients
had a significantly higher frequency of Hb, iron, or vitamin B12 deficiency and of abnormally
elevated blood homocysteine level than healthy control participants (all p < 0.001). Upon
further dividing OLP patients into those with major erosive OLP (MjEOLP; n Z 67), minor
erosive OLP (n Z 202), and nonerosive OLP (NEOLP; n Z 83), we found that MjEOLP patients
had a significantly higher mean homocysteine level than NEOLP patients (p Z 0.035).have no conflicts of interest relevant to this article.
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Oral lichen planus 125Conclusion: We conclude that there is a significant association of deficiencies of Hb, iron, folic
acid, and vitamin B12 and abnormally high blood homocysteine level with OLP. There may be a
close relation of high blood homocysteine level to severity of OLP.
Copyright ª 2014, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Oral lichen planus (OLP) is a chronic immunologic muco-
cutaneous inflammatory oral mucosal disease that affects
0.2e3% of the population.1,2 Clinically, reticular, papular,
erosive, ulcerative, plaque-like, atrophic, and bullous types
of OLP can be identified.2 A previous study showed
involvement of both antigen-specific and nonspecific
mechanisms in OLP. Antigen-specific mechanisms include
antigen presentation by basal keratinocytes and antigen-
specific keratinocyte killing by CD8þ cytotoxic T lympho-
cytes. Nonspecific mechanisms include mast cell degranu-
lation and matrix metalloproteinase activation in OLP
lesions.1 Through mast cell/T-cell interactions in OLP le-
sions, mast cell-released cytokines, chemokines, and ma-
trix metalloproteinases can promote T-cell activation,
migration, proliferation, and differentiation.3 Histological-
ly, OLP is characterized by liquefaction degeneration of
basal epithelial cells and an intraepithelial and sub-
epithelial infiltrate of mononuclear cells, which are pre-
dominantly CD8þ. CD4þ cells can be found mainly in the
deep lamina propria.4 An increase in histocompatibility
leukocyte antigen-DR-positive CD3þ cells in both local
lesional tissues and peripheral blood lymphocytes also in-
dicates T-cell activation in OLP.5,6 The aforementioned
findings suggest that OLP is a T-lymphocyte-mediated in-
flammatory disease.
Because OLP was considered to be a T-lymphocyte-
mediated immunological disorder, only a few studies eval-
uated the hematological abnormalities and nutritional de-
ficiencies in OLP patients.7e9 Nevertheless, deficiencies of
vitamin B12,
7 folate,7e9 iron,7 vitamin B1,
9 and vitamin B6
9
have been reported in a portion of OLP patients. In this
study, we assessed whether there was an intimate associ-
ation of the deficiencies of hemoglobin (Hb), iron, vitamin




The study group consisted of 352 patients (73 men and 279
women; age range, 22e87 years, mean 56.8  14.2 years)
with OLP. The normal control group consisted of 352 age- (
2 years of each patient’s age) and sex-matched healthy
control participants (73 men and 279 women; age range,
22e88 years, mean 55.2  13.7 years). All the patients and
participants (control) were seen consecutively, diagnosed,
and treated in the Department of Dentistry, National
Taiwan University Hospital (Taipei, Taiwan) from July 2007
to June 2014. The 352 OLP patients included 269 (51 menand 218 women) with erosive OLP (EOLP) and 83 (22 men
and 61 women) with nonerosive OLP (NEOLP). They were
selected according to the following criteria: (1) a typical
clinical presentation of radiating grayish-white Wickham
striae, papules, and plaques, separately or in combination
(NEOLP), and erosion or ulceration on the oral mucosa
(EOLP); and (2) biopsy specimens characteristic of OLP, that
is, hyperkeratosis or parakeratosis, a slightly acanthotic
epithelium with liquefaction degeneration of the basal
epithelial cells, a pronounced band-like lymphocytic infil-
trate in the lamina propria, and the absence of epithelial
dysplasia. The EOLP was further divided into the major
(MjEOLP) and minor (MiEOLP) types according to criteria
described previously.10e13 However, all OLP patients with
areca quid chewing habit, autoimmune diseases (such as
systemic lupus erythematosus, rheumatoid arthritis, Sjo¨g-
ren syndrome, pemphigus vulgaris, and cicatricial pemphi-
goid), inflammatory diseases, malignancy, or recent surgery
were excluded. In addition, all OLP patients with serum
creatinine concentrations indicative of renal dysfunction
(men, > 131 mmol/L; women, > 115 mmol/L) and who re-
ported a history of stroke, heavy alcohol use, or diseases of
the liver, kidney, or coronary arteries were also excluded.14
Healthy control participants had either dental caries or
mild periodontal diseases but did not have any oral mucosal
or systemic diseases. None of the OLP patients had taken
any prescription medication for OLP for at least 3 months
prior to entering the study. The blood samples were drawn
from OLP patients and healthy control participants for the
measurement of blood Hb, iron, vitamin B12, folic acid, and
homocysteine concentrations. This study was reviewed and
approved by the Institutional Review Board at the National
Taiwan University Hospital.
Determination of blood Hb, iron, vitamin B12, folic
acid, and homocysteine concentrations
The blood Hb, iron, vitamin B12, folic acid, and homocys-
teine concentrations were determined by the routine tests
performed in the Department of Laboratory Medicine, Na-
tional Taiwan University Hospital.
Statistical analysis
Comparisons of the mean blood levels of Hb, iron, vitamin
B12, folic acid, and homocysteine between 352 OLP patients
and 352 age- and sex-matched healthy control participants
and between MjEOLP and MiEOLP or NEOLP patients were
performed by Student t test. The differences in frequency
of Hb, iron, vitamin B12, or folic acid deficiency and of
abnormally high blood homocysteine level between OLP
patients and healthy control participants and between
Table 1 Mean blood concentrations of hemoglobin, iron, vitamin B12, folic acid, and homocysteine in 352 patients with oral
lichen planus and in 352 age- and sex-matched healthy control participants.
Patients with OLP (n Z 352) Healthy control participants (n Z 352) p
Mean  SD Range Mean  SD Range
Hb (g/dL)
Men (n Z 73) 14.4  1.6 (9.3e16.8) 15.2  0.7 (13.6e16.6) <0.001*
Women (n Z 279) 12.8  1.2 (7.5e16.4) 13.6  0.7 (12.2e15.4) <0.001*
Iron (mg/dL)
Men (n Z 73) 98.6  34.3 (10.0e183.0) 101.8  26.2 (62.0e187.0) 0.527
Women (n Z 279) 86.6  30.9 (16.0e210.0) 99.2  28.0 (60.0e204.0) <0.001*
Vitamin B12 (pg/mL) 605.4  266.2 (150.0e1000.0) 686.7  239.8 (259.0e1000.0) <0.001*
Folic acid (ng/mL) 13.3  5.9 (3.7e24.0) 14.5  6.0 (4.1e24.0) 0.008*
Homocysteine (mM) 8.8  3.3 (3.2e23.8) 8.4  2.0 (4.3e14.3) 0.052
* Comparisons of the mean blood levels of hemoglobin, iron, vitamin B12, folic acid, and homocysteine between 352 OLP patients and 352
age- and sex-matched healthy control participants by Student t test with p < 0.05.
Hb Z hemoglobin; OLP Z oral lichen planus; SD Z standard deviation.
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Chi-square test. The result was considered to be significant
if p < 0.05.Results
The mean blood concentrations of Hb, iron, vitamin B12,
folic acid, and homocysteine in 352 OLP patients and in 352
age- and sex-matched healthy control participants are
presented in Table 1. Because men usually have higher
blood levels of Hb and iron than women, these two mean
levels were calculated separately for men and women. We
found that OLP patients had significantly lower mean Hb
(p < 0.001 for both men and women), iron (p < 0.001 for
women only), vitamin B12 (p < 0.001), and folic acid
(pZ 0.008) levels than healthy control participants (Table
1). In addition, OLP patients had marginally significantly
higher mean homocysteine level (p Z 0.052) than healthy
control participants. Although male OLP patients also had
a lower mean iron level than male healthy control par-
ticipants, the difference was not significant (p Z 0.527;
Table 1).
According to the World Health Organization (WHO)
criteria for iron-deficiency anemia, men with Hb < 13 g/dL
and women with Hb < 12 g/dL were defined as having Hb
deficiency or anemia.15 Furthermore, patients with serum
iron level < 60 mg/dL,16 serum vitamin B12 level < 200 pg/
mL (148 pmol/L),14 or folic acid level < 4 ng/mL (10 nmol/
L)17 were defined as having iron, vitamin B12, or folic acid
deficiency, respectively. In addition, patients with the
blood homocysteine level > 12.4 mmol/L (which was the
mean blood homocysteine level of healthy control partic-
ipants plus two standard deviations) were defined as hav-
ing an abnormally high homocysteine level. Based on the
aforementioned definitions, 77 (21.9%) OLP patients, 48
(13.6%) OLP patients, 25 (7.1%) OLP patients, and 1 (0.3%)
OLP patient were diagnosed as having Hb, iron, vitamin
B12, and folic acid deficiencies, respectively (Table 2).
Moreover, 52 (14.8%) OLP patients had abnormally high
blood homocysteine level (Table 2). OLP patients had asignificantly higher frequency of Hb, iron, or vitamin B12
deficiency and of abnormally elevated blood homocysteine
level than healthy control participants (all p < 0.001;
Table 2).
Defining iron-deficiency anemia as the presence of a Hb
concentration < 13 g/dL for men and < 12 g/dL for
women,15 a mean corpuscular volume  80 fL, and a low
serum iron level (< 60 mg/dL),16 we found that 36 (10.2%) of
the 352 OLP patients could be classified as having iron-
deficiency anemia. In addition, defining pernicious anemia
as the presence of a Hb concentration < 13 g/dL for men
and < 12 g/dL for women,15 a mean corpuscular volume 
100 fL, a low serum vitamin B12 level (< 200 pg/mL), and
serum positivity of gastric parietal cell antibody,14,18 we
discovered that only six (1.7%) of the 352 OLP patients
could be classified as having pernicious anemia. When
applying the WHO criteria for iron-deficiency anemia, these
findings suggest that approximately 10% of the 352 OLP
patients in this study are having iron-deficiency anemia, but
pernicious anemia is infrequently found in the 352 OLP
patients studied.
When the 352 OLP patients were further divided as
having MjEOLP (n Z 67), MiEOLP (n Z 202), and NEOLP
(nZ 83), we found that MjEOLP patients had a significantly
higher mean homocysteine concentration than NEOLP pa-
tients (p Z 0.035; Table 3). However, there were no sig-
nificant differences in the blood levels of Hb, iron, vitamin
B12, and folic acid between 67 MjEOLP patients and 202
MiEOLP patients or 83 NEOLP patients (Table 3). Moreover,
there were no significant differences in the frequencies of
Hb, iron, vitamin B12, and folic acid deficiencies and of
abnormally elevated blood homocysteine level between 67
MjEOLP patients and 202 MiEOLP patients or 83 NEOLP pa-
tients (Table 4).Discussion
The majority of previous studies focused on the immuno-
logical dysregulation in OLP patients.1e6 Thus, hematolog-
ical abnormalities and nutritional deficiencies were
Table 4 Number and percentage of individuals with hemoglobin, iron, vitamin B12, or folic acid deficiency and with abnor-
mally high homocysteine level in the MjEOLP, MiEOLP, and NEOLP groups.
Factor N (%) p* N (%) p*
Patients with
MjEOLP (n Z 67)
Patients with
MiEOLP (n Z 202)
Patients with
NEOLP (n Z 83)
Hemoglobin deficiency
(men < 13 g/dL, women < 12 g/dL)
11 (16.4) 46 (22.8) 0.352 20 (24.1) 0.341
Iron deficiency (<60 mg/dL) 10 (14.9) 26 (12.9) 0.825 12 (14.5) 0.879
Vitamin B12 deficiency (< 200 pg/mL) 6 (9.0) 16 (7.9) 0.992 3 (3.6) 0.306
Folic acid deficiency (< 4 ng/mL) 0 (0) 1 (0.5) 0.561 0 (0) ND
High homocysteine levelsa (> 12.4 mM) 12 (17.9) 34 (16.8) 0.987 6 (7.2) 0.080
* Comparison of frequency of hemoglobin, iron, vitamin B12, or folic acid deficiency and abnormally high blood homocysteine level
between 67 MjEOLP patients and 202 MiEOLP patients or 83 NEOLP patients by Chi-square test.
MiEOLPZ major erosive oral lichen planus; MjEOLPZ minor erosive oral lichen planus; NDZ no difference; NEOLPZ nonerosive oral
lichen planus.
a Patients with high homocysteine level are those with the homocysteine level greater than the mean blood homocysteine level of
healthy control participants plus two standard deviations.
Table 2 Number and percentage of individuals with hemoglobin, iron, vitamin B12, or folic acid deficiency or with abnormally
high homocysteine level in the two study groups.
Factor N (%) p
Patients with
OLP (n Z 352)
Healthy control
participants (n Z 352)
Hemoglobin deficiency (men < 13 g/dL, women < 12 g/dL) 77 (21.9) 0 (0) < 0.001*
Iron deficiency (< 60 mg/dL) 48 (13.6) 0 (0) < 0.001*
Vitamin B12 deficiency (< 200 pg/mL) 25 (7.1) 0 (0) < 0.001*
Folic acid deficiency (< 4 ng/mL) 1 (0.3) 0 (0) > 0.99
High homocysteine levels (>12.4 mM)a 52 (14.8) 11 (3.1) < 0.001 *
OLP patients (N ) Z 352; Healthy control participants (N ) Z 352 age and sex matched.
* Comparison of frequency of hemoglobin, iron, vitamin B12, or folic acid deficiency and of abnormally high blood homocysteine level
between 352 OLP patients and 352 age- and sex-matched healthy control participants by Chi-square test with p < 0.05.
OLP Z oral lichen planus.
a Patients with high homocysteine level are those with the homocysteine level greater than the mean blood homocysteine level of
healthy control participants plus two standard deviations.
Table 3 Mean blood concentrations of hemoglobin, iron, vitamin B12, folic acid, and homocysteine in 67 patients with MjEOLP,
in 202 patients with MiEOLP, and in 83 patients with NEOLP.
Patients with
MjEOLP (n Z 67)
Patients with
MiEOLP (n Z 202)
p* Patients with
NEOLP (n Z 83)
p*
Mean  SD Mean  SD Mean  SD
Hb (g/dL)
Men 14.7  1.2 (n Z 13) 14.4  1.3 (n Z 38) 0.468 14.2  2.1 (n Z 22) 0.439
Women 12.9  1.4 (n Z 54) 12.8  1.2 (n Z 164) 0.611 12.9  1.3 (n Z 61) > 0.99
Iron (mg/dL)
Men 97.0  39.0 (n Z 13) 104.7  30.8 (n Z 38) 0.471 89.2  36.7 (n Z 22) 0.557
Women 83.5  30.1 (n Z 54) 87.3  30.8 (n Z 164) 0.430 87.3  32.1 (n Z 61) 0.516
Vitamin B12 (pg/mL) 620.0  294.3 609.8  269.1 0.793 623.7  251.6 0.934
Folic acid (ng/mL) 13.2  6.1 14.7  6.9 0.114 13.6  5.9 0.685
Homocysteine (mM) 9.5  4.1 8.8  3.2 0.151 8.3  2.8 0.035**
* Comparisons of the mean blood levels of Hb, iron, vitamin B12, folic acid, and homocysteine between 67 MjEOLP patients and 202
MiEOLP patients or 83 NEOLP patients by Student t test.
**p < 0.05 by Student t test.
Hb Z hemoglobin; MiEOLP Z major erosive oral lichen planus; MjEOLP Z minor erosive oral lichen planus; NEOLP Z nonerosive oral
lichen planus; SD Z standard deviation.
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128 H.-M. Chen et al.infrequently investigated in OLP patients. Jolly and Nobile9
found folic acid deficiency (< 3 ng/mL) in five of 34 OLP
patients. They also observed widespread deficiencies or
marginally low levels of vitamins B1 and B6 in both OLP
patients and control participants, suggesting special dietary
habits of the local community and an inadequate intake of
unrefined cereal products such as whole-wheat bread,
which is the main source of vitamins B1 and B6. Challa-
combe7 studied the hematological abnormalities in 103 OLP
patients and demonstrated anemia, low iron, low folate,
and low vitamin B12 in nine (8.7%) OLP patients, 13 (12.6%)
OLP patients, three (2.9%) OLP patients, and two (1.9%)
OLP patients, respectively. Moreover, the prevalence of
hematological abnormalities was significantly greater in
EOLP patients than in NEOLP patients.7 Thongprasom et al8
identified low red cell folate level in 11 (44%) of 25 OLP
patients. However, the serum vitamin B12 levels of OLP
patients were within normal range in their study.8 This
study found that 77 (21.9%) OLP patients, 48 (13.6%) OLP
patients, 25 (7.1%) OLP patients, and one (0.3%) OLP pa-
tients had deficiencies of Hb, iron, vitamin B12, and folic
acid, respectively. OLP patients had a significantly higher
frequency of Hb, iron, or vitamin B12 deficiency than
healthy control participants. Of 352 OLP patients, 36
(10.2%) had iron-deficiency anemia and six (1.7%) had per-
nicious anemia. In addition, EOLP patients did not have a
significantly higher prevalence of hematinic deficiency than
NEOLP patients. The results of previous and present studies
indicate that there is a small group of OLP patients defi-
nitely having anemia or hematinic deficiencies. Therefore,
supplementation of hematinics or multiple B vitamins may
be beneficial for this specific group of OLP patients. Actu-
ally, Jolly and Nobile9 observed good and some improve-
ment in 20 of 41 and nine of 41 vitamin-deficient OLP
patients treated with multiple vitamin supplements,
respectively. However, complete remission of the OLP le-
sions was not seen within 2 months of commencing vitamin
therapy.9 This finding suggests that although the frequency
of hematinic deficiency is significantly higher in OLP pa-
tients than in healthy control participants, hematinic defi-
ciency is probably not the main etiology causing the OLP.
Homocysteine, a sulfur-containing amino acid, is
formed during methionine metabolism.19 Both vitamin B12
and folic acid function as coenzymes that are required for
the conversion of homocysteine to methionine.20 It is
important to monitor the blood homocysteine level
because higher blood homocysteine levels can cause
oxidative stress, damage endothelium, and enhance
thrombogenicity, and are thus associated with increased
rates of coronary heart disease and stroke.19,21e24 In
addition, measurement of both serum methylmalonic acid
and homocysteine levels is found to be a more sensitive
method of screening for vitamin B12 deficiency
(sensitivity Z 99.8%), and thus can be used for detecting
subclinical vitamin B12 deficiency.
25,26 In this study, an
abnormally higher blood homocysteine level was detected
in 14.8% of OLP patients, whereas only 3.1% of healthy
control participants had a higher blood homocysteine
level. The high blood homocysteine level in OLP patients
could be due to deficiencies in folic acid and vitamins B12
and B6, because previous studies have shown that a sup-
plementation with folic acid and vitamins B12 and B6 canreduce blood homocysteine levels.21,27,28 In this study, the
mean vitamin B12 and folic acid levels were significantly
lower in OLP patients than in healthy control participants.
Furthermore, the frequency of vitamin B12 (but not folic
acid) deficiency was significantly higher in OLP patients
than in healthy control participants. Our study also showed
a significantly higher mean blood homocysteine level in
MjEOLP patients than in NEOLP patients. Because patients
with MjEOLP often have more severe and larger recurrent
ulcerative OLP lesions than NEOLP patients, the result of
our study indicates that the severity of OLP may be related
to the elevated homocysteine level in OLP patients.
In our oral mucosal disease clinic, a portion of patients
with atrophic glossitis, burning mouth syndrome, recurrent
aphthous ulcerations, OLP, or antithyroid autoantibodies
are found to have hematinic deficiencies, high blood ho-
mocysteine level, iron-deficiency anemia, or
thalassemia.29e34 Supplementation of multiple B vitamins
including B1, B2, B6, and B12, calcium pantothenate, nico-
tinamide, and folic acid may cause significant reductions in
blood homocysteine level and improvements of oral symp-
toms or signs in patients with atrophic glossitis or burning
mouth syndrome.27,28 These findings suggest that it is very
important to check complete blood count and blood levels
of iron, vitamin B12, and folic acid for patients with atro-
phic glossitis, burning mouth syndrome, recurrent aphthous
ulcerations, or OLP. For those patients with hematinic de-
ficiencies, high blood homocysteine level, or anemia, im-
mediate treatment with multiple B vitamins or specific
deficient hematinics usually results in prompt improvement
of the associated oral diseases.
Our results demonstrated that 77 (21.9%) OLP patients,
48 (13.6%) OLP patients, 25 (7.1%) OLP patients, and one
(0.3%) OLP patient had deficiencies of Hb, iron, vitamin B12,
and folic acid, respectively. Moreover, 52 (14.8%) OLP pa-
tients had abnormally high blood homocysteine level. In
addition, we showed significantly higher frequencies of Hb,
iron, and vitamin B12 deficiencies and of abnormally
elevated blood homocysteine level in our 352 OLP patients
than in the 352 healthy control participants. These findings
suggest there is a significant association of deficiencies of
Hb, iron, and vitamin B12 and abnormally high blood ho-
mocysteine level with OLP. The present study also found
that MjEOLP patients had a significantly higher mean blood
homocysteine level than NEOLP patients. This finding also
indicates a close relation of high blood homocysteine level
to severity of OLP.References
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